Abundance Wealth Counselors Sells 8 Shares of Mettler-Toledo International Inc. (NYSE:MTD)

Abundance Wealth Counselors decreased its position in shares of Mettler-Toledo International Inc. (NYSE:MTD) by 1.2% during the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 676 shares of the medical instruments supplier’s stock after selling 8 shares during the period. Abundance Wealth Counselors’ holdings in Mettler-Toledo International were worth $827,000 as of its most recent filing with the Securities & Exchange Commission.

Other hedge funds and other institutional investors have also made changes to their positions in the company. Blue Trust Inc. grew its holdings in Mettler-Toledo International by 242.9% during the 3rd quarter. Blue Trust Inc. now owns 24 shares of the medical instruments supplier’s stock valued at $34,000 after purchasing an additional 17 shares during the last quarter. Ashton Thomas Securities LLC purchased a new position in Mettler-Toledo International during the 3rd quarter valued at $37,000. Sound Income Strategies LLC grew its position in Mettler-Toledo International by 4,500.0% in the 4th quarter. Sound Income Strategies LLC now owns 46 shares of the medical instruments supplier’s stock valued at $56,000 after acquiring an additional 45 shares during the last quarter. Raleigh Capital Management Inc. increased its stake in Mettler-Toledo International by 272.7% in the third quarter. Raleigh Capital Management Inc. now owns 41 shares of the medical instruments supplier’s stock worth $61,000 after purchasing an additional 30 shares during the period. Finally, Whittier Trust Co. of Nevada Inc. lifted its position in shares of Mettler-Toledo International by 60.0% during the third quarter. Whittier Trust Co. of Nevada Inc. now owns 48 shares of the medical instruments supplier’s stock worth $72,000 after purchasing an additional 18 shares during the last quarter. Hedge funds and other institutional investors own 95.07% of the company’s stock.

Mettler-Toledo International Stock Performance

Shares of Mettler-Toledo International stock opened at $1,365.36 on Friday. Mettler-Toledo International Inc. has a one year low of $1,133.46 and a one year high of $1,546.93. The company has a market capitalization of $28.81 billion, a PE ratio of 36.81, a P/E/G ratio of 4.72 and a beta of 1.12. The company has a 50-day simple moving average of $1,267.00 and a two-hundred day simple moving average of $1,343.65.

Mettler-Toledo International (NYSE:MTD) last posted its earnings results on Thursday, November 7th. The medical instruments supplier reported $10.21 EPS for the quarter, beating analysts’ consensus estimates of $10.00 by $0.21. Mettler-Toledo International had a net margin of 21.15% and a negative return on equity of 531.78%. The company had revenue of $954.54 million during the quarter, compared to analysts’ expectations of $941.93 million. On average, equities analysts predict that Mettler-Toledo International Inc. will post 40.42 earnings per share for the current fiscal year.

Insider Buying and Selling

In other Mettler-Toledo International news, insider Gerry Keller sold 140 shares of the business’s stock in a transaction that occurred on Tuesday, December 3rd. The shares were sold at an average price of $1,254.09, for a total transaction of $175,572.60. Following the sale, the insider now owns 6 shares of the company’s stock, valued at approximately $7,524.54. The trade was a 95.89 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, Director Elisha W. Finney sold 76 shares of the firm’s stock in a transaction on Monday, November 11th. The stock was sold at an average price of $1,311.75, for a total transaction of $99,693.00. Following the completion of the transaction, the director now directly owns 240 shares of the company’s stock, valued at approximately $314,820. This represents a 24.05 % decrease in their position. The disclosure for this sale can be found here. 1.94% of the stock is owned by company insiders.

Wall Street Analysts Forecast Growth

A number of research analysts have recently commented on MTD shares. Stifel Nicolaus cut their price target on shares of Mettler-Toledo International from $1,550.00 to $1,450.00 and set a “buy” rating on the stock in a report on Monday, November 11th. Citigroup raised shares of Mettler-Toledo International from a “sell” rating to a “neutral” rating and raised their target price for the stock from $1,200.00 to $1,300.00 in a research report on Wednesday, December 11th. Robert W. Baird lowered their price target on Mettler-Toledo International from $1,375.00 to $1,310.00 and set a “neutral” rating for the company in a report on Monday, November 11th. Evercore ISI upgraded Mettler-Toledo International from an “in-line” rating to an “outperform” rating and raised their price objective for the stock from $1,375.00 to $1,450.00 in a report on Thursday, January 2nd. Finally, Wolfe Research began coverage on Mettler-Toledo International in a report on Friday, December 13th. They issued a “peer perform” rating for the company. One analyst has rated the stock with a sell rating, six have assigned a hold rating and three have assigned a buy rating to the company. According to data from MarketBeat.com, the stock currently has an average rating of “Hold” and an average target price of $1,351.25.

Mettler-Toledo International Profile

Mettler-Toledo International Inc manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally. It operates through five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. The company’s laboratory instruments include laboratory balances, liquid pipetting solutions, automated laboratory reactors, real-time analytics, titrators, pH meters, process analytics sensors and analyzer technologies, physical value analyzers, density and refractometry, thermal analysis systems, and other analytical instruments; and LabX, a laboratory software platform to manage and analyze data generated from its instruments.